This information was published on 2026-09-03T18:31 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2545668 |
| (220) |
07 May 2025
|
| (300) |
US, 08 Nov 2024, 98843894
|
| (511) (510) |
Class 1
Therapeutic proteins for use in the manufacture of implantable medical devices; targetable bone morphogenetic proteins for use as an inducer of regenerative bone growth media, other than for medical or veterinary purposes Class 10 Medical and surgical instruments for use in bone and joint surgery, regeneration, reconstruction, and augmentation; none of the foregoing being: Implantable scaffolds comprising synthetic materials for maintaining tissue contour; medical implants consisting of synthetic materials; synthetic bone grafts; medical implants comprising natural, non-living materials; implantable scaffolds comprising synthetic materials, namely, fusion cages for spinal surgery and expandable spinal implants; bone void fillers comprised of synthetic materials; bone regeneration matrices; soft tissue regeneration matrices; implantable medical devices to regenerate, repair, or treat soft tissue and bone; synthetic materials for use in bone and joint surgery, bone regeneration, bone reconstruction, and bone augmentation; bone implants composed of synthetic materials; implantable synthetic materials for surgical repair, regeneration, reconstruction, and augmentation of human tissue; non-living tissue substitutes for use in human tissue repair, regeneration, reconstruction, and augmentation; synthetic implantable medical devices for the regeneration of bone defects |
| (540) | AMP2 |
| (550) | Word |
| (730) |
Theradaptive, Inc.
|
| (750) |
By George Legal
|
Find out more about publications on the About page.